PBLA has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
PBLA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).
Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.
Panbela Therapeutics's Predictability Rank is Not Rated. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.
For the Biotechnology subindustry, Panbela Therapeutics's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, Panbela Therapeutics's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:
* The bar in red indicates where Panbela Therapeutics's Margin of Safety % (DCF Dividends Based) falls into.
Thank you for viewing the detailed overview of Panbela Therapeutics's Margin of Safety % (DCF Dividends Based) provided by GuruFocus.com. Please click on the following links to see related term pages.
Jennifer K. Simpson | director, officer: President and CEO | C/O DELCATH SYSTEMS, INC., 810 SEVENTH AVENUE, SUITE 3505, NEW YORK NY 10019 |
Susan Horvath | officer: V.P. of Finance & CFO | 4645 ITHACA LANE, PLYMOUTH MN 55446 |
Jeffrey E. Jacob | director | 712 VISTA BLVD #305, WACONIA MN 55387 |
Daniel Donovan | director | 712 VISTA BLVD #305, WACONIA MN 55387 |
Paul W. Schaffer | director | 712 VISTA BLVD #305, WACONIA MN 55387 |
Arthur Fratamico | director | C/O FLEXION THERAPEUTICS, INC., 10 MALL ROAD, SUITE 301, BURLINGTON MA 01803 |
Ryan R. Gilbertson 2012 Irrevocable Trust | 10 percent owner | 1000 PARKER'S LAKE RD, WAYZATA MN 55391 |
Ryan Randall Gilbertson | 10 percent owner | 130 LAKE ST. WEST, WAYZATA MN 55391 |
Donald Robert Schemel | director | 712 VISTA BLVD #305, WACONIA MN 55387 |
Dalvir S Gill | director | 712 VISTA BLVD SUITE 305, WACONIA MN 55387 |
Scott Kellen | officer: Chief Financial Officer | 3405 ANNAPOLIS LANE, SUITE 200, MINNEAPOLIS MN 55447 |
Jeffrey S Mathiesen | director | 43334 SEVEN MILE RD., SUITE 1000, NORTHVILLE MI 48167 |
Paulson J Robert Jr | director | |
Daniel E. Ryweck | officer: Chief Financial Officer | 712 VISTA BLVD #305, WACONIA MN 55387 |
Michael T. Cullen | director | 712 VISTA BLVD, #305, WACONIA MN 55387 |
From GuruFocus
By Marketwired • 10-25-2023
By Stock market mentor Stock market mentor • 01-12-2023
By sperokesalga sperokesalga • 04-12-2023
By Marketwired • 06-28-2023
By Stock market mentor Stock market mentor • 01-19-2023
By Marketwired • 10-24-2023
By Marketwired • 08-10-2023
By sperokesalga sperokesalga • 02-13-2023
By Marketwired • 09-05-2023
By Marketwired • 09-19-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.